Viking Therapeutics (VKTX) Other financing activities (2015 - 2026)
Viking Therapeutics' (VKTX) quarterly Other financing activities came in at $1.0 million in Q2 2026, up 81.49% year-over-year from $551000.0 in Q2 2025, and up 100.0% quarter-over-quarter from $500000.0 in Q1 2026.
Powered by 
Analysis
Viking Therapeutics (VKTX) Other financing activities (2015 - 2026) Analysis & Trends
Viking Therapeutics has disclosed Other financing activities across 6 years of filings, most recently posting $1.0 million for Q2 2026.
- In Q2 2026, Other financing activities rose 81.49% year-over-year to $1.0 million; the TTM figure through Jun 2026 stood at $2.6 million (down 35.0% YoY), while the FY2025 annual figure was $2.0 million, down 80.77% from the prior year.
- Other financing activities came in at $1.0 million for Q2 2026 at Viking Therapeutics, up from $500000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $4.4 million in Q1 2024 to a low of -$200000.0 in Q4 2023.
- Average Other financing activities over 4 years is $1.6 million, with a median of $664000.0 recorded in 2025.
- Year-over-year, Other financing activities jumped 393.5% in 2024 and slumped 92.0% in 2025.
- Over 4 years, Other financing activities stood at -$200000.0 in 2023, then jumped by 393.5% to $587000.0 in 2024, then climbed by 13.12% to $664000.0 in 2025, then surged by 50.6% to $1.0 million in 2026.
- Per Business Quant data, the three most recent Other financing activities figures were $1.0 million in Q2 2026, $500000.0 in Q1 2026, and $664000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn |
| 10 | Viking Therapeutics | 4.86 Bn | 4.86 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Mar 31, 2026 | 500,000.00 |
| Dec 31, 2025 | 664,000.00 |
| Sep 30, 2025 | 436,000.00 |
| Jun 30, 2025 | 551,000.00 |
| Mar 31, 2025 | 349,000.00 |
| Dec 31, 2024 | 587,000.00 |
| Sep 30, 2024 | 2.51 Mn |
| Jun 30, 2024 | 2.94 Mn |
| Mar 31, 2024 | 4.36 Mn |
| Dec 31, 2023 | -200,000.00 |
| Jun 30, 2023 | 2.60 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2016 | 11,345.00 |
| Dec 31, 2015 | 20,489.00 |
API Access
Viking Therapeutics Other financing activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-financing-activities&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-financing-activities", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-financing-activities&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();